Should we stay or should we go? Recent insights on drug discontinuation in multiple sclerosis by Anne Mrochen, Sven G. Meuth, Steffen Pfeuffer

Get full text

Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis by Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Grote-Levi, Kurt-Wolfram Sühs, Luisa Klotz, Steffen Pfeuffer, Refik Pul, Christoph Kleinschnitz, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz

Get full text

Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis by Alice G. Willison, Ramona Hagler, Margit Weise, Saskia Elben, Niklas Huntemann, Lars Masanneck, Steffen Pfeuffer, Stefanie Lichtenberg, Kristin S. Golombeck, Lara-Maria Preuth, Leoni Rolfes, Menekse Öztürk, Tobias Ruck, Nico Melzer, Melanie Korsen, Stephen L. Hauser, Hans-Peter Hartung, Philipp A. Lang, Marc Pawlitzki, Saskia Räuber, Sven G. Meuth

Get full text